Published in J Lab Clin Med on February 01, 2003
Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation (2005) 2.21
Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil. Transl Res (2006) 1.16
Protective Role of Silymarin and Deferoxamine Against Iron Dextran-induced Renal Iron Deposition in Male Rats. Int J Prev Med (2013) 1.11
Electrocardiographic consequences of cardiac iron overload in thalassemia major. Am J Hematol (2011) 0.91
Influence of iron chelation on R1 and R2 calibration curves in gerbil liver and heart. Magn Reson Med (2008) 0.86
Iron overload decreases CaV1.3-dependent L-type Ca2+ currents leading to bradycardia, altered electrical conduction, and atrial fibrillation. Circ Arrhythm Electrophysiol (2011) 0.86
Antioxidant-mediated effects in a gerbil model of iron overload. Acta Haematol (2007) 0.82
Rapid monitoring of iron-chelating therapy in thalassemia major by a new cardiovascular MR measure: the reduced transverse relaxation rate. NMR Biomed (2010) 0.81
Are there problems with the "time compressed model" of iron overload? J Lab Clin Med (2004) 0.75
The relationship between serum ferritin levels and electrocardiogram characteristics in acutely ill patients. Exp Clin Cardiol (2009) 0.75
Combined histological and hematological assessment of iron-induced organ damage in a gerbil model of iron overload. Am J Transl Res (2015) 0.75
Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood (2010) 3.03
Iron supplementation during pregnancy, anemia, and birth weight: a randomized controlled trial. Am J Clin Nutr (2003) 2.95
Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG. Circ Res (2003) 2.27
Bimodal cardiac dysfunction in an animal model of iron overload. J Lab Clin Med (2002) 2.23
Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood (2011) 1.92
Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol Pharmacol (2004) 1.83
Pentamidine-induced long QT syndrome and block of hERG trafficking. J Pharmacol Exp Ther (2004) 1.76
High-dose primaquine regimens against relapse of Plasmodium vivax malaria. Am J Trop Med Hyg (2008) 1.72
The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations. J Biol Chem (2001) 1.60
Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand. Am J Trop Med Hyg (2003) 1.54
The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes. J Pharmacol Toxicol Methods (2010) 1.44
An Ethiopian pattern of human adaptation to high-altitude hypoxia. Proc Natl Acad Sci U S A (2002) 1.43
HERG-Lite: a novel comprehensive high-throughput screen for drug-induced hERG risk. J Pharmacol Toxicol Methods (2005) 1.35
Variability in the measurement of hERG potassium channel inhibition: effects of temperature and stimulus pattern. J Pharmacol Toxicol Methods (2004) 1.33
MICE models: superior to the HERG model in predicting Torsade de Pointes. Sci Rep (2013) 1.23
Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel. Blood (2010) 1.17
Breathhold multiecho fast spin-echo pulse sequence for accurate R2 measurement in the heart and liver. Magn Reson Med (2009) 1.15
Alfuzosin delays cardiac repolarization by a novel mechanism. J Pharmacol Exp Ther (2007) 1.14
Multi-parameter in vitro toxicity testing of crizotinib, sunitinib, erlotinib, and nilotinib in human cardiomyocytes. Toxicol Appl Pharmacol (2013) 1.11
Myocardial T2 quantitation in patients with iron overload at 3 Tesla. J Magn Reson Imaging (2009) 1.10
Transfusion of stored blood impairs host defenses against Gram-negative pathogens in mice. Transfusion (2014) 1.09
Doppler-defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three years. Br J Haematol (2009) 1.07
Dose ranging studies of new artemisinin-piperaquine fixed combinations compared to standard regimens of artemisisnin combination therapies for acute uncomplicated falciparum malaria. Southeast Asian J Trop Med Public Health (2007) 1.06
Prolonged red cell storage before transfusion increases extravascular hemolysis. J Clin Invest (2016) 0.97
An ion channel library for drug discovery and safety screening on automated platforms. Assay Drug Dev Technol (2008) 0.97
Cerebral malaria: a new way forward with magnetic resonance imaging (MRI). Am J Trop Med Hyg (2009) 0.97
HERG channel trafficking. Novartis Found Symp (2005) 0.95
Optical mapping reveals conduction slowing and impulse block in iron-overload cardiomyopathy. J Lab Clin Med (2003) 0.95
Increased K+ efflux and apoptosis induced by the potassium channel modulatory protein KChAP/PIAS3beta in prostate cancer cells. J Biol Chem (2002) 0.95
Separate MRI quantification of dispersed (ferritin-like) and aggregated (hemosiderin-like) storage iron. Magn Reson Med (2010) 0.94
A history of the role of the hERG channel in cardiac risk assessment. J Pharmacol Toxicol Methods (2013) 0.92
Iron deficiency in whole blood donors. Transfusion (2011) 0.92
Variable expression of long QT syndrome among gene carriers from families with five different HERG mutations. Ann Noninvasive Electrocardiol (2002) 0.92
Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.91
Renal tubular epithelial cell apoptosis is associated with caspase cleavage of the NHE1 Na+/H+ exchanger. Am J Physiol Renal Physiol (2002) 0.90
Efficacy of Artequick versus artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand. Southeast Asian J Trop Med Public Health (2008) 0.90
Methods for noninvasive measurement of tissue iron in Cooley's anemia. Ann N Y Acad Sci (2005) 0.90
Deferoxamine prevents cardiac hypertrophy and failure in the gerbil model of iron-induced cardiomyopathy. J Lab Clin Med (2003) 0.90
Clinical experience with intravenous quinine, intramuscular artemether and intravenous artesunate for the treatment of severe malaria in Thailand. Southeast Asian J Trop Med Public Health (2003) 0.87
Magnetic resonance assessment of iron overload by separate measurement of tissue ferritin and hemosiderin iron. Ann N Y Acad Sci (2010) 0.86
Vanoxerine: cellular mechanism of a new antiarrhythmic. J Cardiovasc Electrophysiol (2009) 0.86
Partition-variant desferrithiocin analogues: organ targeting and increased iron clearance. J Med Chem (2005) 0.86
Hyponatraemia and hypokalaemia in adults with uncomplicated malaria in Thailand. Trop Doct (2008) 0.86
Deferiprone and hepatic fibrosis. Blood (2003) 0.85
Vanoxerine, a new drug for terminating atrial fibrillation and flutter. J Cardiovasc Electrophysiol (2009) 0.84
Increased cardiac risk in concomitant methadone and diazepam treatment: pharmacodynamic interactions in cardiac ion channels. J Cardiovasc Pharmacol (2010) 0.84
Direct block of hERG potassium channels by the protein kinase C inhibitor bisindolylmaleimide I (GF109203X). Cardiovasc Res (2004) 0.83
Evaluating state dependence and subtype selectivity of calcium channel modulators in automated electrophysiology assays. Assay Drug Dev Technol (2014) 0.82
Safety and tolerability of elubaquine (bulaquine, CDRI 80/53) for treatment of Plasmidium vivax malaria in Thailand. Korean J Parasitol (2006) 0.82
Rapid monitoring of iron-chelating therapy in thalassemia major by a new cardiovascular MR measure: the reduced transverse relaxation rate. NMR Biomed (2010) 0.81
Plasma hepcidin of Ethiopian highlanders with steady-state hypoxia. Blood (2013) 0.80
Reduced transverse relaxation rate (RR2) for improved sensitivity in monitoring myocardial iron in thalassemia. J Magn Reson Imaging (2011) 0.79
HBED ligand: preclinical studies of a potential alternative to deferoxamine for treatment of chronic iron overload and acute iron poisoning. Blood (2002) 0.78
Dual-wavelength excitation for fluorescence-based quantification of zinc protoporphyrin IX and protoporphyrin IX in whole blood. J Biophotonics (2013) 0.77
Test article concentrations in the hERG assay: losses through the perfusion, solubility and stability. J Pharmacol Toxicol Methods (2008) 0.77
MR characterization of hepatic storage iron in transfusional iron overload. J Magn Reson Imaging (2013) 0.77
Management of the thalassemias. Cold Spring Harb Perspect Med (2013) 0.76
Oral vanoxerine prevents reinduction of atrial tachyarrhythmias: preliminary results. J Cardiovasc Electrophysiol (2011) 0.76
Measurement and correction of stimulated echo contamination in T2-based iron quantification. Magn Reson Imaging (2012) 0.76
Safety of short-term valacyclovir as an anti-sickling agent in sickle-cell anemia. Pediatr Blood Cancer (2011) 0.75
Robert M. Berne. Biogr Mem Natl Acad Sci (2004) 0.75
Bandwidth-variable tunable optical filter unit for illumination and spectral imaging systems using thin-film optical band-pass filters. Rev Sci Instrum (2013) 0.75